(Q45862776)

17 December 2017

editorial

0 references

title

Next-generation adenoviral vectors: new and improved (English)

1 reference

17 December 2017

1 reference

Amalfitano A

1

1 reference

17 December 2017

publication date

1 October 1999

1 reference

17 December 2017

published in

Gene Therapy

1 reference

17 December 2017

volume

6

1 reference

17 December 2017

issue

10

1 reference

17 December 2017

page(s)

1643-1645

1 reference

17 December 2017

Mechanism of activation of early viral transcription by the adenovirus E1A gene product

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301027

A helper-dependent adenovirus vector system: removal of helper virus by Cre-mediated excision of the viral packaging signal

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301027

Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301027

An adenoviral vector deleted for all viral coding sequences results in enhanced safety and extended expression of a leptin transgene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301027

Persistence in muscle of an adenoviral vector that lacks all viral genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301027

Improved adenovirus packaging cell lines to support the growth of replication-defective gene-delivery vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301027

Isolation and characterization of packaging cell lines that coexpress the adenovirus E1, DNA polymerase, and preterminal proteins: implications for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301027

Persistent transgene expression in mouse liver following in vivo gene transfer with a delta E1/delta E4 adenovirus vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301027

Immune responses to reporter proteins and high viral dose limit duration of expression with adenoviral vectors: comparison of E2a wild type and E2a deleted vectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301027

Persistence of an [E1-, polymerase-] adenovirus vector despite transduction of a neoantigen into immune-competent mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301027

Production and characterization of improved adenovirus vectors with the E1, E2b, and E3 genes deleted

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301027

7 January 2021

Adenoviral preterminal protein stabilizes mini-adenoviral genomes in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301027

7 January 2021

Activation of transgene expression by early region 4 is responsible for a high level of persistent transgene expression from adenovirus vectors in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301027

7 January 2021

Long-term gene delivery into the livers of immunocompetent mice with E1/E4-defective adenoviruses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301027

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3301027

1 reference

17 December 2017

Dimensions Publication ID

1013913991

0 references

1 reference

17 December 2017